Biden Proposal Would Ban Online Prescribing of Certain Drugsnews2023-02-25T10:49:56+00:00February 25th, 2023|The New York Times|
A Fraught New Frontier in Telehealth: Ketaminenews2023-02-20T08:00:06+00:00February 20th, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisisnews2022-12-29T23:46:45+00:00December 29th, 2022|The New York Times|
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuitsnews2022-11-15T19:30:25+00:00November 15th, 2022|The New York Times|
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Findsnews2022-11-09T17:28:16+00:00November 9th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdosesnews2022-07-26T07:02:48+00:00July 26th, 2022|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|
Supreme Court Sides With Doctors Accused of Running Pill Millsnews2022-06-27T18:47:54+00:00June 27th, 2022|The New York Times|
